Correction: Imaging in staging, treatment planning, and monitoring of hepatocellular carcinoma for local and locoregional therapies: consensus recommendations from EORTC and ESGAR (May 23, 10.1007/s00330-025-11699-7, 2025)

Osman Ocal; Christoph Johannes Zech; Maria Antonietta Bali; David Pasquier; Felix Mottaghy; Ingo Einspieler; Nikolaos Kartalis; Irene Bargellini; Roberto Iezzi; Timm Denecke; Wolfgang Gerhard Kunz; Bernhard Gebauer; Henning Wege; Roberto Cannella; Daniela Elena Oprea-Lager; Arndt Vogel; Bruno Sangro; Max Seidensticker

doi:10.1007/s00330-025-12045-7

Correction: Imaging in staging, treatment planning, and monitoring of hepatocellular carcinoma for local and locoregional therapies: consensus recommendations from EORTC and ESGAR (May 23, 10.1007/s00330-025-11699-7, 2025)

Osman Ocal^*
, Christoph Johannes Zech
, Maria Antonietta Bali
, David Pasquier
, Felix Mottaghy
, Ingo Einspieler
, Nikolaos Kartalis
, Irene Bargellini
, Roberto Iezzi
, Timm Denecke
, Wolfgang Gerhard Kunz
, Bernhard Gebauer
, Henning Wege
, Roberto Cannella
, Daniela Elena Oprea-Lager
, Arndt Vogel
, Bruno Sangro
, Max Seidensticker

^*Corresponding author for this work

Research output: Contribution to journal › Erratum / corrigendum › Academic

Abstract

https://doi.org/10.1007/s00330-025-11699-7 published online 23 May 2025. In the original article, affiliation of study group member Lorenza Rimassa’s affiliation was incorrectly given as IRCCS Humanitas Research Hospital, Roma, Italy. The correct affiliation is Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano (Milan), Italy. Lorenza Rimassa is also affiliated with Department of Biomedical Sciences, Humanitas University, Pieve Emanuele (Milan), Italy, which was left out in the original article. Furthermore, the following Conflict of interest statement was missing in the original article: L.R. has received consulting fees from AbbVie, AstraZeneca, Basilea, Bayer, BMS, Elevar Therapeutics, Exelixis, Genenta, Hengrui, Incyte, Ipsen, Jazz Pharmaceuticals, MSD, Nerviano Medical Sciences, Roche, Servier, Taiho Oncology, Zymeworks; lecture fees from AstraZeneca, Bayer, BMS, Eisai, Guerbet, Incyte, Ipsen, Roche, Servier; travel expenses from AstraZeneca, Servier; and institutional research funding from AbbVie, AstraZeneca, BeiGene, Exelixis, Fibrogen, Incyte, Ipsen, Jazz Pharmaceuticals, MSD, Nerviano Medical Sciences, Roche, Servier, Taiho Oncology, TransThera Sciences, Zymeworks. The original article has been corrected.

Original language	English
Pages (from-to)	3331-3332
Number of pages	2
Journal	European Radiology
Volume	36
Issue number	4
DOIs	https://doi.org/10.1007/s00330-025-12045-7
Publication status	Published - Apr 2026

Access to Document

10.1007/s00330-025-12045-7Licence: CC BY

Fingerprint

Dive into the research topics of 'Correction: Imaging in staging, treatment planning, and monitoring of hepatocellular carcinoma for local and locoregional therapies: consensus recommendations from EORTC and ESGAR (May 23, 10.1007/s00330-025-11699-7, 2025)'. Together they form a unique fingerprint.

Cite this

Ocal, O., Zech, C. J., Bali, M. A., Pasquier, D., Mottaghy, F., Einspieler, I., Kartalis, N., Bargellini, I., Iezzi, R., Denecke, T., Kunz, W. G., Gebauer, B., Wege, H., Cannella, R., Oprea-Lager, D. E., Vogel, A., Sangro, B., & Seidensticker, M. (2026). Correction: Imaging in staging, treatment planning, and monitoring of hepatocellular carcinoma for local and locoregional therapies: consensus recommendations from EORTC and ESGAR (May 23, 10.1007/s00330-025-11699-7, 2025). European Radiology, 36(4), 3331-3332. https://doi.org/10.1007/s00330-025-12045-7

@article{b02b11a8977b434982137d07b44cd280,

title = "Correction: Imaging in staging, treatment planning, and monitoring of hepatocellular carcinoma for local and locoregional therapies: consensus recommendations from EORTC and ESGAR (May 23, 10.1007/s00330-025-11699-7, 2025)",

abstract = "https://doi.org/10.1007/s00330-025-11699-7 published online 23 May 2025. In the original article, affiliation of study group member Lorenza Rimassa{\textquoteright}s affiliation was incorrectly given as IRCCS Humanitas Research Hospital, Roma, Italy. The correct affiliation is Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano (Milan), Italy. Lorenza Rimassa is also affiliated with Department of Biomedical Sciences, Humanitas University, Pieve Emanuele (Milan), Italy, which was left out in the original article. Furthermore, the following Conflict of interest statement was missing in the original article: L.R. has received consulting fees from AbbVie, AstraZeneca, Basilea, Bayer, BMS, Elevar Therapeutics, Exelixis, Genenta, Hengrui, Incyte, Ipsen, Jazz Pharmaceuticals, MSD, Nerviano Medical Sciences, Roche, Servier, Taiho Oncology, Zymeworks; lecture fees from AstraZeneca, Bayer, BMS, Eisai, Guerbet, Incyte, Ipsen, Roche, Servier; travel expenses from AstraZeneca, Servier; and institutional research funding from AbbVie, AstraZeneca, BeiGene, Exelixis, Fibrogen, Incyte, Ipsen, Jazz Pharmaceuticals, MSD, Nerviano Medical Sciences, Roche, Servier, Taiho Oncology, TransThera Sciences, Zymeworks. The original article has been corrected.",

author = "Osman Ocal and Zech, \{Christoph Johannes\} and Bali, \{Maria Antonietta\} and David Pasquier and Felix Mottaghy and Ingo Einspieler and Nikolaos Kartalis and Irene Bargellini and Roberto Iezzi and Timm Denecke and Kunz, \{Wolfgang Gerhard\} and Bernhard Gebauer and Henning Wege and Roberto Cannella and Oprea-Lager, \{Daniela Elena\} and Arndt Vogel and Bruno Sangro and Max Seidensticker",

year = "2026",

month = apr,

doi = "10.1007/s00330-025-12045-7",

language = "English",

volume = "36",

pages = "3331--3332",

journal = "European Radiology",

issn = "0938-7994",

publisher = "Springer",

number = "4",

}

Ocal, O, Zech, CJ, Bali, MA, Pasquier, D, Mottaghy, F, Einspieler, I, Kartalis, N, Bargellini, I, Iezzi, R, Denecke, T, Kunz, WG, Gebauer, B, Wege, H, Cannella, R, Oprea-Lager, DE, Vogel, A, Sangro, B & Seidensticker, M 2026, 'Correction: Imaging in staging, treatment planning, and monitoring of hepatocellular carcinoma for local and locoregional therapies: consensus recommendations from EORTC and ESGAR (May 23, 10.1007/s00330-025-11699-7, 2025)', European Radiology, vol. 36, no. 4, pp. 3331-3332. https://doi.org/10.1007/s00330-025-12045-7

Correction: Imaging in staging, treatment planning, and monitoring of hepatocellular carcinoma for local and locoregional therapies: consensus recommendations from EORTC and ESGAR (May 23, 10.1007/s00330-025-11699-7, 2025). / Ocal, Osman; Zech, Christoph Johannes; Bali, Maria Antonietta et al.
In: European Radiology, Vol. 36, No. 4, 04.2026, p. 3331-3332.

Research output: Contribution to journal › Erratum / corrigendum › Academic

TY - JOUR

T1 - Correction: Imaging in staging, treatment planning, and monitoring of hepatocellular carcinoma for local and locoregional therapies

T2 - consensus recommendations from EORTC and ESGAR (May 23, 10.1007/s00330-025-11699-7, 2025)

AU - Ocal, Osman

AU - Zech, Christoph Johannes

AU - Bali, Maria Antonietta

AU - Pasquier, David

AU - Mottaghy, Felix

AU - Einspieler, Ingo

AU - Kartalis, Nikolaos

AU - Bargellini, Irene

AU - Iezzi, Roberto

AU - Denecke, Timm

AU - Kunz, Wolfgang Gerhard

AU - Gebauer, Bernhard

AU - Wege, Henning

AU - Cannella, Roberto

AU - Oprea-Lager, Daniela Elena

AU - Vogel, Arndt

AU - Sangro, Bruno

AU - Seidensticker, Max

PY - 2026/4

Y1 - 2026/4

N2 - https://doi.org/10.1007/s00330-025-11699-7 published online 23 May 2025. In the original article, affiliation of study group member Lorenza Rimassa’s affiliation was incorrectly given as IRCCS Humanitas Research Hospital, Roma, Italy. The correct affiliation is Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano (Milan), Italy. Lorenza Rimassa is also affiliated with Department of Biomedical Sciences, Humanitas University, Pieve Emanuele (Milan), Italy, which was left out in the original article. Furthermore, the following Conflict of interest statement was missing in the original article: L.R. has received consulting fees from AbbVie, AstraZeneca, Basilea, Bayer, BMS, Elevar Therapeutics, Exelixis, Genenta, Hengrui, Incyte, Ipsen, Jazz Pharmaceuticals, MSD, Nerviano Medical Sciences, Roche, Servier, Taiho Oncology, Zymeworks; lecture fees from AstraZeneca, Bayer, BMS, Eisai, Guerbet, Incyte, Ipsen, Roche, Servier; travel expenses from AstraZeneca, Servier; and institutional research funding from AbbVie, AstraZeneca, BeiGene, Exelixis, Fibrogen, Incyte, Ipsen, Jazz Pharmaceuticals, MSD, Nerviano Medical Sciences, Roche, Servier, Taiho Oncology, TransThera Sciences, Zymeworks. The original article has been corrected.

AB - https://doi.org/10.1007/s00330-025-11699-7 published online 23 May 2025. In the original article, affiliation of study group member Lorenza Rimassa’s affiliation was incorrectly given as IRCCS Humanitas Research Hospital, Roma, Italy. The correct affiliation is Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano (Milan), Italy. Lorenza Rimassa is also affiliated with Department of Biomedical Sciences, Humanitas University, Pieve Emanuele (Milan), Italy, which was left out in the original article. Furthermore, the following Conflict of interest statement was missing in the original article: L.R. has received consulting fees from AbbVie, AstraZeneca, Basilea, Bayer, BMS, Elevar Therapeutics, Exelixis, Genenta, Hengrui, Incyte, Ipsen, Jazz Pharmaceuticals, MSD, Nerviano Medical Sciences, Roche, Servier, Taiho Oncology, Zymeworks; lecture fees from AstraZeneca, Bayer, BMS, Eisai, Guerbet, Incyte, Ipsen, Roche, Servier; travel expenses from AstraZeneca, Servier; and institutional research funding from AbbVie, AstraZeneca, BeiGene, Exelixis, Fibrogen, Incyte, Ipsen, Jazz Pharmaceuticals, MSD, Nerviano Medical Sciences, Roche, Servier, Taiho Oncology, TransThera Sciences, Zymeworks. The original article has been corrected.

U2 - 10.1007/s00330-025-12045-7

DO - 10.1007/s00330-025-12045-7

M3 - Erratum / corrigendum

SN - 0938-7994

VL - 36

SP - 3331

EP - 3332

JO - European Radiology

JF - European Radiology

IS - 4

ER -

Ocal O, Zech CJ, Bali MA, Pasquier D, Mottaghy F, Einspieler I et al. Correction: Imaging in staging, treatment planning, and monitoring of hepatocellular carcinoma for local and locoregional therapies: consensus recommendations from EORTC and ESGAR (May 23, 10.1007/s00330-025-11699-7, 2025). European Radiology. 2026 Apr;36(4):3331-3332. doi: 10.1007/s00330-025-12045-7